RxSight Market Cap

RxSight has a market cap or net worth of $2.15 billion as of September 18, 2024. Its market cap has increased by 106.58% in one year.

Market Cap

2.15B

Enterprise Value

1.93B

1-Year Change

106.58%

Ranking

#1863

Market Cap Chart

Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $2.15B, an increase of 406.49%. That is a compound annual growth rate of 67.73%.

Market Cap History

Date	Market Cap	% Change
Sep 17, 2024	2.23B	54.08%
Dec 29, 2023	1.45B	311.70%
Dec 30, 2022	351.20M	14.14%
Dec 31, 2021	307.70M	-27.49%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Privia Health Group	2.27B
Vericel	2.25B
Intellia Therapeutics	2.24B
Harmony Biosciences Holdings	2.21B
Centessa Pharmaceuticals	2.18B
Progyny	2.18B
Novavax	2.18B
Keros Therapeutics	2.14B

Market Cap Rankings